Medfinder
Back to blog

Updated: February 12, 2026

Vistaril Shortage: What Providers and Prescribers Need to Know in 2026

Author

Peter Daggett

Peter Daggett

Healthcare provider reviewing drug shortage data

A clinical guide for providers on Vistaril (hydroxyzine) availability in 2026: current shortage status, therapeutic alternatives, and how to help your patients fill their prescriptions.

Hydroxyzine (Vistaril) has been subject to ongoing supply disruptions since 2019. As a prescriber, understanding the nuances of this shortage — particularly the distinction between formulations, salt forms, and available generic manufacturers — is essential to helping your patients access this medication. This guide provides a clinical overview of the current situation and practical guidance for managing affected patients.

Current Availability Status (2026)

The availability picture for hydroxyzine varies significantly by formulation:

Hydroxyzine pamoate capsules (Vistaril equivalent): ASHP shortage bulletin active since March 2019. Pfizer (brand Vistaril) is no longer marketing this product. Generics available from Amneal, Teva, Sandoz, Chartwell. Distribution is uneven; localized stock-outs are common. Note: Avet's generic received a BX rating in September 2021 and is no longer considered therapeutically equivalent.

Hydroxyzine HCl tablets: No current shortage. Multiple manufacturers. Generally widely stocked. This is the preferred fallback prescription when pamoate capsules are unavailable.

Hydroxyzine HCl injection: Persistent shortage. American Regent is the sole U.S. supplier and has experienced manufacturing delays. Particularly impactful for anesthesia and procedural sedation contexts.

Clinical Distinction: Pamoate vs. HCl

Hydroxyzine pamoate and hydroxyzine hydrochloride deliver the same active drug and are therapeutically equivalent for anxiety, pruritus, and sedation. The difference is the salt form, which affects formulation:

Pamoate: Available as capsules and oral suspension. Subject to shortage.

HCl: Available as tablets (10 mg, 25 mg, 50 mg) and oral syrup (10 mg/5 mL). More widely stocked.

For most outpatient patients taking hydroxyzine for anxiety or allergic pruritus, switching from hydroxyzine pamoate capsules to hydroxyzine HCl tablets at the equivalent dose is clinically appropriate and requires only a prescription update. Documenting this rationale in the chart is good practice.

Therapeutic Alternatives by Indication

If hydroxyzine in all oral forms is unavailable or unsuitable, consider the following alternatives:

For anxiety (short-term, as-needed):

Buspirone 5-15 mg TID for ongoing treatment (2-4 week onset; not for acute relief)

Propranolol 10-40 mg PRN for situational/somatic anxiety symptoms (off-label; non-controlled)

Short-term low-dose benzodiazepine (lorazepam 0.5-1 mg, diazepam 2-5 mg) for acute situations — Schedule IV, use with caution and document rationale

For anxiety (long-term, maintenance):

SSRI (sertraline, escitalopram, fluoxetine) — first-line for GAD, widely available as generics

SNRI (venlafaxine XR, duloxetine) — FDA-approved for GAD

For allergic pruritus / urticaria:

Cetirizine 10 mg daily (OTC, second-generation, minimal sedation)

Loratadine 10 mg daily (OTC, non-sedating)

Fexofenadine 180 mg daily (OTC, minimal sedation, minimal interactions)

For preoperative sedation (injectable shortage):

Midazolam (where available) — most common alternative for procedural anxiolysis

Lorazepam oral/IV — reasonable alternative depending on clinical context

Prescribing Recommendations to Improve Fillability

The following prescribing practices can significantly reduce the likelihood your patient will have trouble filling their hydroxyzine prescription:

Write for "hydroxyzine HCl tablets" rather than "hydroxyzine pamoate capsules" or "Vistaril" when the HCl form is clinically acceptable — it is far more consistently available.

If writing for pamoate, note "Substitution permitted" and indicate that hydroxyzine HCl tablets are an acceptable generic substitute.

Communicate to patients that "Vistaril" by brand name may not be findable and that generic hydroxyzine is equivalent.

How medfinder Can Help Your Patients

For patients struggling to locate hydroxyzine in stock, medfinder for providers allows you to direct patients to a service that calls pharmacies near them and texts them results. This reduces patient frustration, decreases calls back to your office, and helps ensure continuity of care when the drug is hard to find at a particular pharmacy.

For a detailed workflow guide, see our provider's guide to helping patients find Vistaril in stock.

Frequently Asked Questions

Yes, for most clinical indications they are therapeutically equivalent — both deliver the same active drug, hydroxyzine. The HCl form (tablets, oral syrup) is more widely stocked than pamoate capsules in 2026. A prescription update is typically needed since they are technically different formulations.

For anxiety: buspirone (non-controlled, for ongoing use) or SSRIs (first-line for GAD). For acute anxiety, a short-term low-dose benzodiazepine with appropriate documentation. For allergic pruritus: cetirizine, loratadine, or fexofenadine (all OTC, second-generation antihistamines).

No. In September 2021, the FDA changed Avet's hydroxyzine pamoate capsules from an AB rating (therapeutically equivalent) to BX (therapeutic equivalence not yet established). Pharmacists should be aware of this when substituting. Amneal, Teva, Sandoz, and Chartwell generics may have different ratings — confirm with your pharmacy.

Tell patients that the brand-name Vistaril is no longer marketed by Pfizer, but generic hydroxyzine is available from multiple manufacturers. Let them know availability varies by pharmacy and that asking for 'generic hydroxyzine' rather than 'Vistaril' by name is helpful. Recommend medfinder as a tool to help locate stock.

No — the injectable shortage (hydroxyzine HCl IM, from American Regent) primarily affects inpatient and procedural settings. Outpatient oral prescriptions for anxiety and allergic conditions are unaffected by the injectable shortage.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Vistaril also looked for:

37,044 have already found their meds with Medfinder.

Start your search today.

37K+
5-star ratingTrusted by 37,044 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?